PropertyValue
?:abstract
  • Evidence suggests that asymptomatic and mild SARS-CoV-2 infections comprise > 95% of all cases. Developing a test that indicates past infection and possible immunity against the virus is important. We administered 244 antibody tests to three groups of high-risk population. The test consisted of an IgG component and an IgM component. The overall IgM/IgG positivity for patients with none, mild, moderate, and severe symptoms were 21.1%, 21.8%, 14.2%, and 26.9%, respectively. Those with moderate or severe symptoms were no more or less likely to have positive antibody tests than those with no or mild symptoms.
is ?:annotates of
?:creator
?:doi
  • 10.1007/s10096-020-04111-3
?:doi
?:journal
  • Eur_J_Clin_Microbiol_Infect_Dis
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/b80b07cfd66d036a26c4fd6f43ba0a5ea133649d.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7688294.xml.json
?:pmcid
?:pmid
?:pmid
  • 33241444.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • COVID-19 IgG/IgM antibody testing in Los Angeles County, California
?:type
?:year
  • 2020-11-25

Metadata

Anon_0  
expand all